Publikationen in Zusammenarbeit mit Forschern von University of Paris-Saclay (19)

2024

  1. Fifty years of sciences with Patrick Couvreur: A tribute to Professor Patrick Couvreur: a creative and visionary scientist in the field of nanomedicine

    Drug Delivery and Translational Research

2021

  1. Author Correction: DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death (Scientific Reports, (2021), 11, 1, (16793), 10.1038/s41598-021-95976-7)

    Scientific Reports

  2. Collection and storage of human white blood cells for analysis of DNA damage and repair activity using the comet assay in molecular epidemiology studies

    Mutagenesis, Vol. 36, Núm. 3, pp. 193-211

  3. DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death

    Scientific Reports, Vol. 11, Núm. 1

  4. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors

    ChemMedChem, Vol. 16, Núm. 24, pp. 3730-3738

  5. The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confounders

    Mutation Research - Reviews in Mutation Research, Vol. 787

  6. The p.E152K-STIM1 mutation deregulates Ca2+ signaling contributing to chronic pancreatitis

    Journal of Cell Science, Vol. 134, Núm. 3

2020

  1. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

  2. Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice

    International Journal of Pharmaceutics, Vol. 582

2012

  1. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 81, Núm. 3, pp. 514-523

2011

  1. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery

    Expert Opinion on Drug Delivery, Vol. 8, Núm. 6, pp. 721-734

2009

  1. Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel

    European Journal of Pharmaceutical Sciences, Vol. 38, Núm. 4, pp. 405-413

2008

  1. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 1, pp. 98-108

2002

  1. In vitro antileishmanial activity of amphotericin B loaded in poly(ε-caprolactone) nanospheres

    Journal of Drug Targeting, Vol. 10, Núm. 8, pp. 593-599

2000

  1. Bioadhesive potential of gliadin nanoparticulate systems

    European Journal of Pharmaceutical Sciences, Vol. 11, Núm. 4, pp. 333-341

  2. In vitro reversion of amphotericin B resistance in Leishmania donovani by Poloxamer 188

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 8, pp. 2190-2192

1997

  1. Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation method

    Journal of Controlled Release, Vol. 43, Núm. 1, pp. 81-87

  2. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides

    Advanced Drug Delivery Reviews, Vol. 28, Núm. 1, pp. 85-96

1996

  1. Brain delivery of the cholecystokinin agonist pBC 264 using PLG microspheres

    Proceedings of the Controlled Release Society